Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital

Anaerobe

Volumn 18, Issue 1, 2012, Pages 169-171

  Toprak, Nurver Ulger ^a   Uzunkaya, Ozlem D ^a   Sóki, József ^b   Soyletir, Guner ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Antimicrobial resistance; Bacteroides fragilis; Carbapenem; IS elements; Metronidazole

Indexed keywords

4 NITROIMIDAZOLE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; IMIPENEM; MEROPENEM; METRONIDAZOLE;

AGAR DILUTION; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTEROIDES (CLASS); BACTEROIDES FRAGILIS; CFIA GENE; CONCENTRATION RESPONSE; DNA SEQUENCE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INSERTION SEQUENCE; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; NIM GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTEROIDES; BACTEROIDES INFECTIONS; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HOSPITALS, UNIVERSITY; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; TURKEY;

BACTEROIDES; BACTEROIDES FRAGILIS;

EID: 84856753113     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.10.004     Document Type: Article

References (17)

1. Finegold S.M. Anaerobic bacteria: general concepts. Principles and practice of infectious diseases 2005, 2519-2575. Churchill Livingstone, Philadelphia. 5th ed. L.G. Mandell, J.E. Bennett, R. Dolin (Eds.).
2. Goldstein E.J., Finegold S.M., Harrell L.J., Hecht D.W., Jenkins S.G., Pierson C., et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother 2007, 51:1649-1655.
3. Nagy E., Urbán E., Nord C.E., et al. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect 2011, 17:371-379.
4. Yamazoe K., Kato K., Kato H., Tanaka K., Katagiri Y., Watanabe K. Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance. Antimicrob Agents Chemother 1999, 43:2808-2810.
5. Liu C.Y., Huang Y.T., Liao C.H., Yen L.C., Lin H.Y., Hsueh P.R. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrob Agents Chemother 2008, 52:3161-3168.
6. Clinical and Laboratory Standards Institute Methods for antimicrobial susceptibility testing of anaerobic bacteri, approved standards 2007, M11-A7, CLSI, Pennsylvania, USA. 7th ed.
7. Thompson J.S., Malamy M.H. Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (cfiA) from Bacteroides fragilis TAL 2480 reveals strong similarity between cfiA and Bacillus cereus beta-lactamase II. JBacteriol 1990, 172:2584-2593.
8. Gutacker M., Valsangiacomo C., Piffaretti J.C. Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes. Microbiology 2000, 146:1241-1254.
9. Trinh S., Haggoud A., Reysset G., Sebald M. Plasmids pIP419 and pIP421 from Bacteroides: 5-nitroimidazole resistance genes and their upstream insertion sequence elements. Microbiology 1995, 141:927-935.
10. Rasmussen B.A., Kovacs E. Identification and DNA sequence of a new Bacteroides fragilis insertion sequence-like element. Plasmid 1991, 25:141-144.
11. Podglajen I., Breuil J., Collatz E. Insertion of a novel DNA sequence, IS1186, upstream of the silent carbapenenase gene, cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol Microbiol 1994, 12:105-114.
12. Podglajen I., Breuil J., Rohaut A., Monsempes C., Collatz E. Multiple mobile promoter regions for the rare carbapenem resistance gene of Bacteroides fragilis. JBacteriol 2001, 183:3531-3535.
13. Benson D.A., Boguski M.S., Lipman D.J., Ostell J. GenBank. Nucleic Acids Res 1997, 25:1-6.
14. Ulger (Toprak) N., Celik C., Cakici O., Soyletir G. Antimicrobial susceptibilities of Bacteroides fragilis and Bacteroides thetaiotaomicron strains isolated from clinical specimens and human intestinal microbiota. Anaerobe 2004, 10:255-259.
15. Edwards R., Hawkyard C.V., Garvey M.T., Greenwood D. Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK. JAntimicrob Chemother 1999, 43:273-276.
16. Podglajen I., Breuil J., Casin I., Collatz E. Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. JBacteriol 1995, 177:5270-5275.
17. Soki J., Urban E., Szoke I., Fodor E., Nagy E. Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary. JMed Microbiol 2000, 49:427-430.